• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1β通过CD25 +效应T细胞的扩增打破免疫耐受。

IL-1 beta breaks tolerance through expansion of CD25+ effector T cells.

作者信息

O'Sullivan Brendan J, Thomas Helen E, Pai Saparna, Santamaria Pere, Iwakura Yoichiro, Steptoe Raymond J, Kay Thomas W H, Thomas Ranjeny

机构信息

Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.

出版信息

J Immunol. 2006 Jun 15;176(12):7278-87. doi: 10.4049/jimmunol.176.12.7278.

DOI:10.4049/jimmunol.176.12.7278
PMID:16751371
Abstract

IL-1 is a key proinflammatory driver of several autoimmune diseases including juvenile inflammatory arthritis, diseases with mutations in the NALP/cryopyrin complex and Crohn's disease, and is genetically or clinically associated with many others. IL-1 is a pleiotropic proinflammatory cytokine; however the mechanisms by which increased IL-1 signaling promotes autoreactive T cell activity are not clear. Here we show that autoimmune-prone NOD and IL-1 receptor antagonist-deficient C57BL/6 mice both produce high levels of IL-1, which drives autoreactive effector cell expansion. IL-1beta drives proliferation and cytokine production by CD4(+)CD25(+)FoxP3(-) effector/memory T cells, attenuates CD4(+)CD25(+)FoxP3(+) regulatory T cell function, and allows escape of CD4(+)CD25(-) autoreactive effectors from suppression. Thus, inflammation or constitutive overexpression of IL-1beta in a genetically predisposed host can promote autoreactive effector T cell expansion and function, which attenuates the ability of regulatory T cells to maintain tolerance to self.

摘要

白细胞介素-1(IL-1)是多种自身免疫性疾病的关键促炎驱动因子,包括青少年特发性关节炎、NALP/冷吡啉复合物发生突变的疾病以及克罗恩病,并且在基因或临床上与许多其他疾病相关。IL-1是一种多效性促炎细胞因子;然而,IL-1信号增强促进自身反应性T细胞活性的机制尚不清楚。在此我们表明,易患自身免疫性疾病的非肥胖糖尿病(NOD)小鼠和缺乏白细胞介素-1受体拮抗剂的C57BL/6小鼠均产生高水平的IL-1,其驱动自身反应性效应细胞扩增。白细胞介素-1β(IL-1β)可驱动CD4(+)CD25(+)FoxP3(-)效应/记忆T细胞增殖并产生细胞因子,减弱CD4(+)CD25(+)FoxP3(+)调节性T细胞功能,并使CD4(+)CD25(-)自身反应性效应细胞逃脱抑制。因此,在遗传易感性宿主中,IL-1β的炎症或组成性过表达可促进自身反应性效应T细胞扩增和功能,这会减弱调节性T细胞维持自身耐受性的能力。

相似文献

1
IL-1 beta breaks tolerance through expansion of CD25+ effector T cells.白细胞介素-1β通过CD25 +效应T细胞的扩增打破免疫耐受。
J Immunol. 2006 Jun 15;176(12):7278-87. doi: 10.4049/jimmunol.176.12.7278.
2
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.胸腺与自身免疫:CD25⁺CD4⁺自然无反应性及抑制性T细胞的产生作为胸腺维持免疫自身耐受的关键功能。
J Immunol. 1999 May 1;162(9):5317-26.
3
Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.恒定自然杀伤T细胞对1型糖尿病的保护作用需要CD4+CD25+调节性T细胞的活性。
J Immunol. 2006 Sep 15;177(6):3695-704. doi: 10.4049/jimmunol.177.6.3695.
4
Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.保护性白细胞介素-2等位基因变体对NOD小鼠体内CD4+ Foxp3+调节性T细胞功能及自身免疫性糖尿病抗性的影响
J Immunol. 2008 Nov 1;181(9):6283-92. doi: 10.4049/jimmunol.181.9.6283.
5
Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.MHC-II的条件性消融表明MHC-II在调节性CD4 T细胞维持中起间接作用。
J Immunol. 2006 Jun 1;176(11):6503-11. doi: 10.4049/jimmunol.176.11.6503.
6
CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia.CD25+Foxp3+调节性T细胞在淋巴细胞减少恢复过程中促进CD4+T细胞克隆无能的诱导。
J Immunol. 2006 May 15;176(10):5880-9. doi: 10.4049/jimmunol.176.10.5880.
7
T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.非肥胖型糖尿病小鼠中的调节性 T 细胞对 IL-2 刺激的反应性较低,并表现出与失能相关和泛素化因子的差异表达。
Front Immunol. 2019 Nov 25;10:2665. doi: 10.3389/fimmu.2019.02665. eCollection 2019.
8
Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.自身免疫性糖尿病发展过程中致病性T细胞和抑制性T细胞的动态变化。
J Immunol. 2003 Oct 15;171(8):4040-7. doi: 10.4049/jimmunol.171.8.4040.
9
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.由CD25+CD4+天然无反应性和抑制性T细胞维持的免疫自身耐受性:通过打破其无反应性/抑制状态诱导自身免疫性疾病。
Int Immunol. 1998 Dec;10(12):1969-80. doi: 10.1093/intimm/10.12.1969.
10
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.肿瘤坏死因子(TNF)与2型肿瘤坏死因子受体(TNF receptor type 2)的相互作用可促进小鼠CD4+CD25+调节性T细胞的扩增及功能。
J Immunol. 2007 Jul 1;179(1):154-61. doi: 10.4049/jimmunol.179.1.154.

引用本文的文献

1
The impact of donor diabetes on corneal transplant immunity.供体糖尿病对角膜移植免疫的影响。
Am J Transplant. 2023 Sep;23(9):1345-1358. doi: 10.1016/j.ajt.2023.05.027. Epub 2023 May 26.
2
rs3806265 and rs4612666 of the Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes.rs3806265 和 rs4612666 基因与 1 型糖尿病谷氨酸脱羧酶抗体滴度相关。
Front Endocrinol (Lausanne). 2022 Apr 21;13:835054. doi: 10.3389/fendo.2022.835054. eCollection 2022.
3
Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses.
炎性小体对Th1、Th2和Th17免疫反应激活的作用。
Front Microbiol. 2022 Mar 17;13:851835. doi: 10.3389/fmicb.2022.851835. eCollection 2022.
4
Hybrid computational modeling demonstrates the utility of simulating complex cellular networks in type 1 diabetes.混合计算模型证明了模拟 1 型糖尿病中复杂细胞网络的实用性。
PLoS Comput Biol. 2021 Sep 27;17(9):e1009413. doi: 10.1371/journal.pcbi.1009413. eCollection 2021 Sep.
5
Treg-Resistant Cytotoxic CD4 T Cells Dictate T Helper Cells in Their Vicinity: TH17 Skewing and Modulation of Proliferation.抗调节性T细胞的细胞毒性CD4 T细胞决定其附近的辅助性T细胞:TH17偏向及增殖调节
Int J Mol Sci. 2021 May 26;22(11):5660. doi: 10.3390/ijms22115660.
6
Interleukin-1 as Innate Mediator of T Cell Immunity.白细胞介素-1 作为 T 细胞免疫的先天介质。
Front Immunol. 2021 Jan 27;11:621931. doi: 10.3389/fimmu.2020.621931. eCollection 2020.
7
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease.白细胞介素-1(IL-1)的激活的替代途径,及其在健康和疾病中的作用。
Front Immunol. 2020 Dec 18;11:613170. doi: 10.3389/fimmu.2020.613170. eCollection 2020.
8
Predicting Success of Allergen-Specific Immunotherapy.预测变应原特异性免疫治疗的疗效。
Front Immunol. 2020 Aug 25;11:1826. doi: 10.3389/fimmu.2020.01826. eCollection 2020.
9
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.炎性小体介导的临床及实验性疫苗佐剂的免疫原性
Vaccines (Basel). 2020 Sep 22;8(3):554. doi: 10.3390/vaccines8030554.
10
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets.炎症小体在多发性硬化症中的作用及其作为治疗靶点的潜力。
J Neuroinflammation. 2020 Sep 2;17(1):260. doi: 10.1186/s12974-020-01944-9.